Tech Company Financing Transactions

Esperion Therapeutics Funding Round

On 4/25/2013, Esperion Therapeutics raised $33 million in financing from Longitude Capital Management, Aisling Capital and Alta Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

3891 Ranchero Dr. 150
Ann Arbor, MI 48108
USA

Phone

Undisclosed

Website

www.esperion.com

Email Address

Not Recorded

Overview

Emerging pharmaceutical company company focused on the research, development & commercialization of therapies for statin-intolerant patients with elevated

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Tim Mayleben

        

Chief Financial Officer

Rick Bartram

        

Chief Technical Officer

Ken Fiorelli

        

VP - Bus. Development

William Sasiela

        

VP - Regulatory Affairs

Ashley Hall

        

Browse more venture capital transactions:

Prev: 4/25/2013: SchoolChapters venture capital transaction
Next: 4/25/2013: 3scale venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary